Lymphoma immunotyping by paraffin immunoperoxidase and cell suspension methods--a comparative study
Pathology
|July 1, 1986
Summary
Enzyme-digested immunoperoxidase staining effectively identifies B cell lymphoproliferative disorders. This method aids diagnosis, especially when fresh tissue or cell suspension studies are unavailable.
Area of Science:
- Hematology
- Immunohistochemistry
- Oncology
Background:
- Lymphoproliferative disorders encompass a range of B and T cell malignancies.
- Accurate diagnosis relies on distinguishing between monoclonal (malignant) and polyclonal (reactive) lymphoid proliferations.
- Traditional methods may require fresh tissue or specialized equipment.
Purpose of the Study:
- To evaluate the utility of immunoperoxidase staining with enzyme digestion on paraffin-embedded lymph node biopsies.
- To assess the diagnostic accuracy of this method for various lymphoproliferative disorders.
- To compare results with dispersed cell studies.
Main Methods:
- Immunoperoxidase staining was performed on 84 paraffin-embedded biopsy cases.
- An enzyme digestion step was incorporated into the staining protocol.
- Results were compared with dispersed cell studies in 56 overlapping cases.
Main Results:
- Monoclonality was confirmed in 100% of plasmacytomas and 66% of non-Hodgkin's lymphomas.
- IgM was the predominant immunoglobulin class (83%) in lymphomas, with kappa light chain restriction (64%).
- Polyclonality was observed in reactive lymphoid hyperplasia (89%) and Hodgkin's disease (55%).
Conclusions:
- Enzyme-digested immunoperoxidase staining is a valuable tool for diagnosing B cell lymphoproliferative disorders.
- This technique offers a reliable alternative in settings lacking cell suspension studies or fresh tissue access.
- The method demonstrates high sensitivity for detecting monoclonality in specific lymphoid neoplasms.
More Related Videos
07:52Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
09:58Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
Published on: January 7, 2019
